Last 12 months
Inside the activity.
0 purchase rows · 29 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 8 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 24, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionCommon Stock | 156,282 | $86.63 | $13,538,709.66 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · nonDerivative · entry 11 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 491,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 24, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
SaleCommon Stock | 126,126 | $140.12 | $17,672,775.12 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · nonDerivative · entry 10 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,833 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. F8 · price: This transaction was executed in multiple trades at prices ranging from $140.00 to $140.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 24, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionCommon Stock | 126,126 | $103.57 | $13,062,869.82 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · nonDerivative · entry 9 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 42,568 | $86.63 Strike: $86.63 | $3,687,665.84 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · derivative · entry 14 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,136 Underlying: Common Stock · 42,568 shares Expires 2029-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. F11 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 34,898 | $103.57 Strike: $103.57 | $3,614,385.86 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · derivative · entry 13 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,163 Underlying: Common Stock · 34,898 shares Expires 2028-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. F10 · derivative.exercise_date: The options vested in three annual installments beginning with the first on February 19, 2019, the second on February 19, 2020 and the final on February 19, 2021. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
SaleCommon Stock | 300 | $142.24 | $42,672.00 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · nonDerivative · entry 8 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,833 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. F7 · price: This transaction was executed in multiple trades at prices ranging from $142.21 to $142.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
SaleCommon Stock | 1,000 | $141.51 | $141,509.00 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · nonDerivative · entry 7 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,133 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. F6 · price: This transaction was executed in multiple trades at prices ranging from $141.11 to $141.93. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
SaleCommon Stock | 41,268 | $140.12 | $5,782,430.89 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · nonDerivative · entry 6 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 336,133 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. F5 · price: This transaction was executed in multiple trades at prices ranging from $140.00 to $140.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionCommon Stock | 42,568 | $86.63 | $3,687,665.84 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · nonDerivative · entry 5 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,401 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
SaleCommon Stock | 200 | $142.26 | $28,451.00 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · nonDerivative · entry 4 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,833 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. F4 · price: This transaction was executed in multiple trades at prices ranging from $142.22 to $142.29. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
SaleCommon Stock | 800 | $141.54 | $113,233.60 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · nonDerivative · entry 3 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,033 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. F3 · price: This transaction was executed in multiple trades at prices ranging from $141.11 to $141.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
SaleCommon Stock | 33,898 | $140.12 | $4,749,923.35 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 335,833 F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. F2 · price: This transaction was executed in multiple trades at prices ranging from $140.00 to $140.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 23, 2022 Filed May 25, 2022 20:31 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Exercise / conversionCommon Stock | 34,898 | $103.57 | $3,614,385.86 |
DisclosureSEC source: 0001022079-22-000102 · wf-form4_165351065441914.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,731 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on April 22, 2022. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:26 UTC |
Lassiter Wright IIIDirector
|
GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000089 · wf-form4_165307839400151.xml · nonDerivative · entry 1 Lassiter Wright III · CIK 0001805909 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,633 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes approximately 60 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 18, 2022 Filed May 20, 2022 16:41 UTC |
WILENSKY GAIL RDirector
|
GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000096 · wf-form4_165307923862619.xml · nonDerivative · entry 1 WILENSKY GAIL R · CIK 0001018538 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,137 F1 · security: Represents an award of restricted stock units. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:44 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
Tax withholdingCommon Stock | 8 | $136.98 | $1,095.84 |
DisclosureSEC source: 0001022079-22-000097 · wf-form4_165307945293358.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,006 F1 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted share units. F2 · balance_after: The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:39 UTC |
Doi TraceyDirector
|
GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000095 · wf-form4_165307914110326.xml · nonDerivative · entry 1 Doi Tracey · CIK 0001527766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,209 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes approximately 12 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:37 UTC |
RING TIMOTHY MDirector
|
GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000094 · wf-form4_165307903851442.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,933 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes approximately 407 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:35 UTC |
PFEIFFER GARY MDirector
|
GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000093 · wf-form4_165307889530308.xml · nonDerivative · entry 1 PFEIFFER GARY M · CIK 0001127304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,982 F1 · security: Represents an award of restricted stock units. F2 · balance_after: The amount includes approximately 425 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:34 UTC |
MAIN TIMOTHY LDirector
|
GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000092 · wf-form4_165307881385942.xml · nonDerivative · entry 1 MAIN TIMOTHY L · CIK 0001196744 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,243 F1 · security: Represents an award of restricted share units. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:31 UTC |
Gregg Vicky BDirector
|
GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000091 · wf-form4_165307863530124.xml · nonDerivative · entry 2 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,922 F3 · security: Represents an award of restricted share units. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:29 UTC |
MORRISON DENISE MDirector
|
GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000090 · wf-form4_165307852380808.xml · nonDerivative · entry 1 MORRISON DENISE M · CIK 0001230166 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,540 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes approximately 42 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:40 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionNon-Qualifed Stock Option (right to buy) · Derivative | 50,604 | $66.51 Strike: $66.51 | $3,365,672.04 |
DisclosureSEC source: 0001022079-22-000077 · wf-form4_165299279355521.xml · derivative · entry 4 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,604 shares Expires 2026-02-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested in three equal annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:40 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 50,604 | $139.97 | $7,082,991.28 |
DisclosureSEC source: 0001022079-22-000077 · wf-form4_165299279355521.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,224 F1 · price: This transaction was executed in multiple trades at prices ranging from $139.56 to $140.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 17, 2022 Filed May 19, 2022 20:40 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Exercise / conversionCommon Stock | 50,604 | $66.51 | $3,365,672.04 |
DisclosureSEC source: 0001022079-22-000077 · wf-form4_165299279355521.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,828 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 18, 2022 Filed May 20, 2022 20:31 UTC |
Gregg Vicky BDirector
|
OtherCommon Stock | 61 | $134.88 | $8,227.68 |
DisclosureSEC source: 0001022079-22-000091 · wf-form4_165307863530124.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,630 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transactions early on this Form 4. F2 · balance_after: The amount includes approximately 169 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrored a dividend reinvestment plan that was sponsored by the registrant through February 2022. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 20:33 UTC |
RING TIMOTHY MDirector
|
GrantPhantom Stock Units · Derivative | 306 | $135.45 Strike: $0.00 | $41,446.17 |
DisclosureSEC source: 0001022079-22-000066 · wf-form4_164910434883118.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,991.022 Underlying: Common Stock · 306 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 21:50 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 6,228 | $135.21 | $842,087.88 |
DisclosureSEC source: 0001022079-22-000060 · wf-form4_164686263665528.xml · nonDerivative · entry 3 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,224 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on August 31, 2020. Read SEC document |
| March 08, 2022 Filed Mar 9, 2022 21:40 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
SaleCommon Stock | 7,032 | $135.21 | $950,796.72 |
DisclosureSEC source: 0001022079-22-000054 · wf-form4_164686200422046.xml · nonDerivative · entry 3 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,733 F3 · kind: The sale reported was effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on October 29, 2021. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:58 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
Tax withholdingCommon Stock | 79 | $130.09 | $10,277.11 |
DisclosureSEC source: 0001022079-22-000064 · wf-form4_164686306614597.xml · nonDerivative · entry 4 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,011 F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:58 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
GrantCommon Stock | 206 | $130.09 | $26,798.54 |
DisclosureSEC source: 0001022079-22-000064 · wf-form4_164686306614597.xml · nonDerivative · entry 3 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,089 F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:58 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
Tax withholdingCommon Stock | 835 | $130.09 | $108,625.15 |
DisclosureSEC source: 0001022079-22-000064 · wf-form4_164686306614597.xml · nonDerivative · entry 2 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,883 F2 · kind: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:58 UTC |
Deppe Michael JVP, Corp. Controller & CAO
|
GrantCommon Stock | 2,310 | $130.09 | $300,507.90 |
DisclosureSEC source: 0001022079-22-000064 · wf-form4_164686306614597.xml · nonDerivative · entry 1 DEPPE MICHAEL J · CIK 0001771759 · VP, Corp. Controller & CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,718 F1 · kind: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:53 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
Tax withholdingCommon Stock | 32,570 | $130.09 | $4,237,031.30 |
DisclosureSEC source: 0001022079-22-000062 · wf-form4_164686279064545.xml · nonDerivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334,833 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:53 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
GrantCommon Stock | 70,184 | $130.09 | $9,130,236.56 |
DisclosureSEC source: 0001022079-22-000062 · wf-form4_164686279064545.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 367,403 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:50 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
Tax withholdingCommon Stock | 5,316 | $130.09 | $691,558.44 |
DisclosureSEC source: 0001022079-22-000060 · wf-form4_164686263665528.xml · nonDerivative · entry 2 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,452 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:50 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
GrantCommon Stock | 11,544 | $130.09 | $1,501,758.96 |
DisclosureSEC source: 0001022079-22-000060 · wf-form4_164686263665528.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,768 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:48 UTC |
GUINAN MARKExecutive Vice President & CFO
|
Tax withholdingCommon Stock | 10,475 | $130.09 | $1,362,692.75 |
DisclosureSEC source: 0001022079-22-000058 · wf-form4_164686249689113.xml · nonDerivative · entry 2 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,981 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:48 UTC |
GUINAN MARKExecutive Vice President & CFO
|
GrantCommon Stock | 20,780 | $130.09 | $2,703,270.20 |
DisclosureSEC source: 0001022079-22-000058 · wf-form4_164686249689113.xml · nonDerivative · entry 1 GUINAN MARK · CIK 0001505998 · Executive Vice President & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,456 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:44 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
Tax withholdingCommon Stock | 7,947 | $130.09 | $1,033,825.23 |
DisclosureSEC source: 0001022079-22-000056 · wf-form4_164686226802115.xml · nonDerivative · entry 2 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,391 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:44 UTC |
EGLINTON MANNER CARRIESVP, Advanced Diagnostics
|
GrantCommon Stock | 16,162 | $130.09 | $2,102,514.58 |
DisclosureSEC source: 0001022079-22-000056 · wf-form4_164686226802115.xml · nonDerivative · entry 1 EGLINTON MANNER CARRIE · CIK 0001696776 · SVP, Advanced Diagnostics 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,338 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:40 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
Tax withholdingCommon Stock | 6,360 | $130.09 | $827,372.40 |
DisclosureSEC source: 0001022079-22-000054 · wf-form4_164686200422046.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,765 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:40 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
GrantCommon Stock | 13,392 | $130.09 | $1,742,165.28 |
DisclosureSEC source: 0001022079-22-000054 · wf-form4_164686200422046.xml · nonDerivative · entry 1 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,125 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:36 UTC |
Davis J. E.EVP-Gen. Diagnostics/CEO Elect
|
Tax withholdingCommon Stock | 10,330 | $130.09 | $1,343,829.70 |
DisclosureSEC source: 0001022079-22-000052 · wf-form4_164686177213744.xml · nonDerivative · entry 2 Davis J. E. · CIK 0001599837 · EVP-Gen. Diagnostics/CEO Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,808 F2 · shares: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award. Read SEC document |
| March 07, 2022 Filed Mar 9, 2022 21:36 UTC |
Davis J. E.EVP-Gen. Diagnostics/CEO Elect
|
GrantCommon Stock | 19,856 | $130.09 | $2,583,067.04 |
DisclosureSEC source: 0001022079-22-000052 · wf-form4_164686177213744.xml · nonDerivative · entry 1 Davis J. E. · CIK 0001599837 · EVP-Gen. Diagnostics/CEO Elect 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,138 F1 · shares: Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2019, approved in accordance with the requirements of Rule 16b-3(d). Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 21:44 UTC |
PREVOZNIK MICHAEL ESVP & General Counsel
|
SaleCommon Stock | 661 | $130.00 | $85,930.00 |
DisclosureSEC source: 0001022079-22-000050 · wf-form4_164625742745510.xml · nonDerivative · entry 1 PREVOZNIK MICHAEL E · CIK 0001222679 · SVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,224 Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:53 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 109,317 | $0.00 Strike: $127.73 | $0.00 |
DisclosureSEC source: 0001022079-22-000041 · wf-form4_164609595731029.xml · derivative · entry 2 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 109,317 Underlying: Common Stock · 109,317 shares Expires 2032-02-24 F2 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:53 UTC |
RUSCKOWSKI STEPHEN HDirector · Chairman, CEO and President
|
GrantCommon Stock | 22,510 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000041 · wf-form4_164609595731029.xml · nonDerivative · entry 1 RUSCKOWSKI STEPHEN H · CIK 0001142624 · Director · Chairman, CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 297,219 F1 · security: Represents an award of restricted share units. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:50 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
GrantNon-Qualifed Stock Option (right to buy) · Derivative | 16,155 | $0.00 Strike: $127.73 | $0.00 |
DisclosureSEC source: 0001022079-22-000039 · wf-form4_164609580400204.xml · derivative · entry 4 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,155 Underlying: Common Stock · 16,155 shares Expires 2032-02-24 F4 · derivative.exercise_date: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date. Read SEC document |
| February 24, 2022 Filed Mar 1, 2022 00:50 UTC |
Doherty Catherine T.SVP, Group Exec. Clin. Fran.
|
GrantCommon Stock | 3,328 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000039 · wf-form4_164609580400204.xml · nonDerivative · entry 2 Doherty Catherine T. · CIK 0001520897 · SVP, Group Exec. Clin. Fran. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,733 F2 · security: Represents an award of restricted share units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.